Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow Exchange is developing software to distribute IPO bids

2/21/24 MOEX

Moscow Exchange is preparing 7-8 new IPOs right now

2/21/24 MOEX

Transneft completes share split

2/20/24 TRNFP

Polymetal's shares will be transferred to the third listing level

2/20/24 POLY

X5 Group to buy Forward-Market

2/20/24 X5

VTB earns record profit in 2023

2/20/24 VTBR

VTB plans reverse split of shares at a ratio of 5000 to 1

2/20/24 VTBR

Sistema is considering a new dividend policy

2/20/24 AFKS

Segezha reported for 2023 by RAS

2/19/24 SGZH

Rosneft in 2023 to increase gas production by 25%

2/19/24 ROSN